Pages that link to "Q33225207"
Jump to navigation
Jump to search
The following pages link to Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema (Q33225207):
Displaying 50 items.
- Macular grid laser photocoagulation for branch retinal vein occlusion (Q24187991) (← links)
- Intravitreal steroids for macular edema in diabetes (Q24242456) (← links)
- Clinical development of new treatments for diabetic macular oedema (Q26825365) (← links)
- Intravitreal Bevacizumab Alone versus Combined with Macular Photocoagulation in Diabetic Macular Edema (Q30473844) (← links)
- Clinical trials on corticosteroids for diabetic macular edema (Q31146864) (← links)
- Intravitreal triamcinolone as an adjunct in the treatment of concomitant proliferative diabetic retinopathy and diffuse diabetic macular oedema. Combined IVTA and laser treatment for PDR with CSMO. (Q33278337) (← links)
- Emerging pharmacotherapies for diabetic macular edema (Q33304852) (← links)
- Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities (Q33320830) (← links)
- Endoplasmic reticulum stress and diabetic retinopathy (Q33352111) (← links)
- A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema (Q33355710) (← links)
- Combined intravitreal triamcinolone injection and laser photocoagulation in eyes with persistent macular edema after branch retinal vein occlusion. (Q33360807) (← links)
- Emerging drugs for diabetic retinopathy (Q33388498) (← links)
- Comparison of combination posterior sub-tenon triamcinolone and modified grid laser treatment with intravitreal triamcinolone treatment in patients with diffuse diabetic macular edema (Q33395775) (← links)
- Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy (Q33431322) (← links)
- Steroid injection in addition to macular laser grid photocoagulation in diabetic macular oedema: a systematic review (Q33539977) (← links)
- Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema (Q33542959) (← links)
- Update on nonsurgical therapy for diabetic macular edema (Q33852871) (← links)
- Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results (Q33959122) (← links)
- Diabetic macular edema: therapeutic options (Q34185374) (← links)
- Pathophysiology and treatment of diabetic retinopathy (Q34528134) (← links)
- Current treatments in diabetic macular oedema: systematic review and meta-analysis (Q34606190) (← links)
- Diabetic retinopathy - An update (Q34957902) (← links)
- Branch retinal vein occlusion: treatment modalities: an update of the literature (Q35028773) (← links)
- Combined therapy for diabetic macular edema (Q35067115) (← links)
- Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion. (Q35098562) (← links)
- Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions (Q35635355) (← links)
- Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. (Q35762482) (← links)
- Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial. (Q35835522) (← links)
- Macular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema: a result from five randomized controlled trials (Q38637505) (← links)
- Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion (Q36490483) (← links)
- Substance P promotes the recovery of oxidative stress-damaged retinal pigmented epithelial cells by modulating Akt/GSK-3β signaling (Q37170497) (← links)
- Current and future approaches in the prevention and treatment of diabetic retinopathy. (Q37221516) (← links)
- Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population (Q37477129) (← links)
- Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization (Q37627442) (← links)
- Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema (Q38104680) (← links)
- Cystoid macular edema (Q41278732) (← links)
- Early Avastin management in acute retinal vein occlusion (Q41843477) (← links)
- Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis (Q41878593) (← links)
- Combined triamcinolone acetonide injection and grid laser photocoagulation: a promising treatment for diffuse diabetic macular oedema? (Q42339090) (← links)
- A trial of topical prednisolone acetate before intravitreal triamcinolone acetonide decreases intraocular pressure spikes (Q42905213) (← links)
- Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion. (Q43150600) (← links)
- Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion (Q43288447) (← links)
- Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion (Q45753852) (← links)
- Association between photoreceptor integrity and visual outcome in diabetic macular edema (Q52615600) (← links)
- Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion (Q53392620) (← links)
- Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection. (Q53487609) (← links)
- Bioactive Lipids and Pathological Retinal Angiogenesis (Q57052936) (← links)
- Intravitreal steroids for the treatment of retinal diseases (Q59101228) (← links)
- Diabetic macular edema: Evidence-based management (Q59797366) (← links)
- Intravitreal triamcinolone for diffuse diabetic macular oedema (Q80159651) (← links)